Qlife Holding AB stock analysis
Qlife Holding AB (4HG0) Stock Price & Analysis
4HG0 Stock Chart & Stats
- Day’s Range
- EUR 0.07 - EUR 0.07
- 52-Week Range
- EUR 0.06 - EUR 0.28
- Previous Close
- EUR 0.08
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 2.55M
- Enterprise Value
- EUR 35.56M
- Total Cash (Recent Filing)
- EUR 1.90M
- Total Debt (Recent Filing)
- EUR 8.17M
- Price to Earnings (P/E)
- ―
- Beta
- 1.33
- Next Earnings
- Feb 10, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Point-of-care Diagnostic Platform
Qlife’s focus on point-of-care and near-patient testing addresses the need for faster, decentralized analysis outside centralized laboratories. If the platform gains adoption, this model can support recurring use across healthcare and other testing environments over multiple quarters.
Recurring Consumables Model
The combination of analyzers with single-use cartridges or reagents can create repeat purchasing as instruments are deployed. An installed-base-driven consumables stream may improve revenue visibility and deepen customer retention if the company expands utilization.
Historical Equity Strength
Positive shareholders’ equity in 2021–2022 shows that Qlife has previously operated with a stronger capital base than its recent position. Although later deterioration is a major concern, this history indicates the balance sheet has not always been structurally impaired.
Bears Say
Negative Equity And Debt
Negative equity combined with debt materially reduces financial flexibility and leaves fewer internal resources to absorb operating setbacks. This capital structure can increase dependence on recapitalization or external funding and constrain investment in commercial expansion.
Persistent Cash Burn
Ongoing negative operating and free cash flow indicates that the business is not currently self-funding its operations. Continued cash burn can require external financing, limit strategic flexibility, and increase execution risk while the company seeks to scale.
Unprofitable And Contracting Operations
Small and declining revenue alongside deeply negative profitability shows that Qlife has not yet reached a sustainable cost structure. Persistent losses weaken the capacity to reinvest internally and make future growth dependent on improving scale, margins, or funding access.
4HG0 FAQ
What was Qlife Holding AB’s price range in the past 12 months?
What is Qlife Holding AB’s market cap?
When is Qlife Holding AB’s upcoming earnings report date?
How were Qlife Holding AB’s earnings last quarter?
Is Qlife Holding AB overvalued?
Does Qlife Holding AB pay dividends?
What is Qlife Holding AB’s EPS estimate?
How many shares outstanding does Qlife Holding AB have?
What happened to Qlife Holding AB’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Qlife Holding AB?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Qlife Holding AB
Operating as a medical technology firm, Qlife Holding AB (publ) specializes in the production and distribution of in-vitro diagnostic instruments and their associated chemical reagents. Their flagship offering is the Egoo.Health Platform, a comprehensive system comprising a measuring device, single-use test capsules, and integrated software. This innovative platform facilitates the detection of various biomarkers or viral agents, with each capsule tailored for a distinct diagnostic purpose. The range of supported biomarkers encompasses C-reactive protein for home-based monitoring, Phenylalanine (PHE) vital for managing Phenylketonuria (PKU) in patients, and a multiplex test designed to identify Sars-CoV-2 and Influenza, aiding in the detection of viral and bacterial infections. Established in 2019, Qlife's operations are headquartered in Helsingborg, Sweden.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Thomas Warthoe
- Employees
- 2
- Website
- www.qlifeholding.com
- Address
- Ullevigatan 19, Gothenburg, AB, 411 40, SE
Qlife Holding AB (4HG0) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 9 | 4 | 9 |
| Technical Analysis | 3 | 4 | 3 |
| Moving Averages | 6 | 0 | 6 |

